[Journal logo]

Volume 64 
Part 11 
Pages o2136-o2137  
November 2008  

Received 15 September 2008
Accepted 25 September 2008
Online 18 October 2008

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.009 Å
R = 0.054
wR = 0.124
Data-to-parameter ratio = 20.8
Details
Open access

(E)-1,1'-Bis[(E)-but-2-enyl]-3,3'-(propane-1,3-diyl)bis(1H-benzimidazol-3-ium) dibromide monohydrate

aDepartment of Physics, Faculty of Arts and Sciences, Erciyes University, 38039 Kayseri, Turkey,bDepartment of Chemistry, Faculty of Arts and Sciences, Adiyaman University, Adiyaman, Turkey,cDepartment of Chemistry, Faculty of Arts and Sciences, Ínönü University, 44280 Malatya, Turkey, and dDepartment of Physics, Faculty of Arts and Sciences, Ondokuz Mayis University, 55139 Samsun, Turkey
Correspondence e-mail: akkurt@erciyes.edu.tr

The title compound, C25H30N42+·2Br-·H2O, was synthesized from 1,1'-propylenedibenzimidazole and (E)-1-bromobut-2-ene in dimethylformamide solution. The two benzimidazole ring systems are essentially planar, with maximum deviations of 0.011 (4) and 0.023 (3) Å. The dihedral angle between these two ring systems is 25.87 (15)°. The crystal structure is stabilized by intermolecular O-H...Br and C-H...Br hydrogen-bonding interactions. Atmospheric water was incorporated into the crystal structure.

Related literature

For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]). For general background, see: Sakai et al. (1989[Sakai, T., Hamada, T., Awata, N. & Watanabe, J. (1989). J. Pharmacobiodyn. 12, 530-536.]); Tidwell et al. (1993[Tidwell, R. R., Jones, S. K., Naiman, N. A., Berger, L. C., Brake, W. B., Dykstra, C. C. & Hall, J. E. (1993). Antimicrob. Agents Chemother. 37, 1713-1716.]); Küçükbay et al. (1995[Küçükbay, H., Çetinkaya, E. & Durmaz, R. (1995). Arzneim. Forsch. 45, 1331-1334.], 2001[Küçükbay, H., Durmaz, R., Güven, M. & Günal, S. (2001). Arzneim. Forsch. 51, 420-424.]); Turner & Denny (1996[Turner, P. R. & Denny, W. A. (1996). Mutat. Res. 335, 141-169.]); Hall et al. (1998[Hall, J. E., Kerrigan, J. E., Ramachandran, K., Bender, B. C., Stanko, J. P., Jones, S. K., Patric, D. A. & Tidwell, R. R. (1998). Antimicrob. Agents Chemother. 42, 666-674.]). For related structures, see, for example: Öztürk et al. (2003[Öztürk, S., Akkurt, M., Küçükbay, H., Okuyucu, N. & Fun, H.-K. (2003). Acta Cryst. E59, o1014-o1016.]); Akkurt et al. (2003[Akkurt, M., Öztürk, S., Küçükbay, H., Okuyucu, N. & Fun, H.-K. (2003). Acta Cryst. E59, o786-o788.], 2006[Akkurt, M., Yildirim, S. Ö., Küçükbay, H., Sireci, N. & Büyükgüngör, O. (2006). Acta Cryst. E62, o3184-o3186.]).

[Scheme 1]

Experimental

Crystal data
  • C25H30N42+·2Br-·H2O

  • Mr = 564.35

  • Triclinic, [P \overline 1]

  • a = 8.7989 (9) Å

  • b = 11.1878 (13) Å

  • c = 14.8813 (14) Å

  • [alpha] = 106.381 (8)°

  • [beta] = 96.490 (8)°

  • [gamma] = 106.227 (8)°

  • V = 1319.9 (3) Å3

  • Z = 2

  • Mo K[alpha] radiation

  • [mu] = 3.09 mm-1

  • T = 296 K

  • 0.53 × 0.45 × 0.31 mm

Data collection
  • Stoe IPDSII diffractometer

  • Absorption correction: integration (X-RED32; Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.291, Tmax = 0.447

  • 16109 measured reflections

  • 6181 independent reflections

  • 4101 reflections with I > 2[sigma](I)

  • Rint = 0.063

Refinement
  • R[F2 > 2[sigma](F2)] = 0.054

  • wR(F2) = 0.124

  • S = 1.05

  • 6181 reflections

  • 297 parameters

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 0.56 e Å-3

  • [Delta][rho]min = -0.41 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
O1-HW1...Br1 0.81 (8) 2.54 (8) 3.342 (6) 171 (8)
O1-HW2...Br2i 0.89 (9) 2.45 (8) 3.333 (5) 171 (7)
C4-H4A...Br2ii 0.97 2.81 3.773 (4) 172
C4-H4B...Br2i 0.97 2.86 3.802 (6) 164
C11-H11...Br1 0.93 2.76 3.536 (4) 142
C12-H12A...Br2 0.97 2.89 3.822 (5) 161
C19-H19...Br2iii 0.93 2.92 3.816 (5) 162
C21-H21...Br1 0.93 2.65 3.550 (5) 162
Symmetry codes: (i) x+1, y, z; (ii) -x+1, -y+1, -z+1; (iii) -x, -y, -z.

Data collection: X-AREA (Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]); cell refinement: X-AREA; data reduction: X-RED32 (Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]); program(s) used to solve structure: SIR97 (Altomare et al., 1999[Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ2540 ).


Acknowledgements

The authors acknowledge the Faculty of Arts and Sciences, Ondokuz Mayis University, Turkey, for the use of the diffractometer (purchased under grant F.279 of the University Research Fund). HK and NS thank Inönü University Research Fund (directed project BAPB-2007-46) for financial support for this study.

References

Akkurt, M., Öztürk, S., Küçükbay, H., Okuyucu, N. & Fun, H.-K. (2003). Acta Cryst. E59, o786-o788.  [CSD] [CrossRef] [details]
Akkurt, M., Yildirim, S. Ö., Küçükbay, H., Sireci, N. & Büyükgüngör, O. (2006). Acta Cryst. E62, o3184-o3186.  [CrossRef] [details]
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.  [ISI] [CrossRef] [ChemPort] [details]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [ChemPort] [details]
Hall, J. E., Kerrigan, J. E., Ramachandran, K., Bender, B. C., Stanko, J. P., Jones, S. K., Patric, D. A. & Tidwell, R. R. (1998). Antimicrob. Agents Chemother. 42, 666-674.  [ChemPort] [PubMed]
Küçükbay, H., Çetinkaya, E. & Durmaz, R. (1995). Arzneim. Forsch. 45, 1331-1334.
Küçükbay, H., Durmaz, R., Güven, M. & Günal, S. (2001). Arzneim. Forsch. 51, 420-424.
Öztürk, S., Akkurt, M., Küçükbay, H., Okuyucu, N. & Fun, H.-K. (2003). Acta Cryst. E59, o1014-o1016.  [CSD] [CrossRef] [details]
Sakai, T., Hamada, T., Awata, N. & Watanabe, J. (1989). J. Pharmacobiodyn. 12, 530-536.  [ChemPort] [PubMed]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.
Tidwell, R. R., Jones, S. K., Naiman, N. A., Berger, L. C., Brake, W. B., Dykstra, C. C. & Hall, J. E. (1993). Antimicrob. Agents Chemother. 37, 1713-1716.  [ChemPort] [PubMed] [ISI]
Turner, P. R. & Denny, W. A. (1996). Mutat. Res. 335, 141-169.


Acta Cryst (2008). E64, o2136-o2137   [ doi:10.1107/S160053680803095X ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.